Cargando…
Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy
PURPOSE: To assess the safety and efficacy of the serotonin–norepinephrine reuptake inhibitor desvenlafaxine in adults with painful diabetic peripheral neuropathy (DPN). CLINICALTRIALS.GOV IDENTIFIERS: NCT00283842, NCT01050218. PATIENTS AND METHODS: This was a 13-week, randomized, double-blind, plac...
Autores principales: | Allen, Rob, Sharma, Uma, Barlas, Suna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075949/ https://www.ncbi.nlm.nih.gov/pubmed/25018648 http://dx.doi.org/10.2147/JPR.S55682 |
Ejemplares similares
-
Desvenlafaxine
por: Andrade, Chittaranjan
Publicado: (2009) -
Desvenlafaxine in the treatment of major depressive disorder
por: Lourenco, Maria Teresa C, et al.
Publicado: (2009) -
Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
por: Umland, Elena M, et al.
Publicado: (2012) -
Painful Diabetic Peripheral Neuropathy – A Survey of Patient Experiences
por: Abd-Elsayed, Alaa A, et al.
Publicado: (2023) -
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
por: Jang, Han Na, et al.
Publicado: (2023)